Furthermore, DCISM was associated with more aggressive tumor characteristics like higher rates of oestrogen receptor (ER) and progesterone receptor (PR) negativity, HER2 positivity, and lymph node metastasis. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.